Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Health Benefits of Tart Cherry in Ulcerative Colitis [NA]
A completed clinical trial investigates the health benefits of tart cherry in individuals with ulcerative colitis. The study status is compl…
-
FDA approval · 2025-01-23FDA Approved: MESALAMINE — Supplemental Application (Encube Ethicals, Inc.)
FDA approved a supplemental application for mesalamine submitted by Encube Ethicals, Inc.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis
A head-to-head clinical trial is planned to compare ustekinumab with infliximab for ulcerative colitis, with the study currently not recruit…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
This clinical trial update notes recruitment status for evaluating the efficacy and safety of upadacitinib in inflammatory bowel disease, in…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2, Phase 3]
This multicenter, randomized, double-blind, placebo-controlled induction study evaluated the efficacy and safety of risankizumab for moderat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC [NA]
Open-label pediatric trial evaluating the safety and efficacy of QD for induction of remission in Ulcerative Colitis has completed.
-
FDA approval · 2025-01-15FDA Approved: OMVOH — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for OMVOH (mirikizumab-MRKZ) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Autoimmune Protocol Diet and Inflammatory Bowel Disease [NA]
The clinical trial evaluating the autoimmune protocol diet for inflammatory bowel disease has completed, and results have been posted. Condi…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease. [Phase 4]
A Phase 4 trial sponsored by the University of Manitoba is evaluating bowel preparation for colonoscopy in people with Crohn's disease or ul…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis [Phase 1]
This Phase 1 clinical trial assesses the safety and tolerability of NP-201 Acetate Injection in healthy adult volunteers and in patients wit…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease [Phase 4]
This update describes ongoing Phase 4 research on de-escalating anti-TNF therapy for inflammatory bowel disease, including Crohn's disease a…
-
CLINICAL_TRIALS research · 2025-01-03Clinical Trial Update: Chronic Care Model on Symptom Status, Stress and Quality of Life in Individuals With Inflammatory Bowel Disease [NA]
This clinical trial update describes the status of a study evaluating a chronic care model's impact on symptoms, stress, and quality of life…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease [Phase 1]
A Phase 1 clinical trial update for TQH3906 capsules in adults with moderately to severely active ulcerative colitis or Crohn's disease, wit…
-
CLINICAL_TRIALS other · 2025-01-01Clinical Trial Update: Early Inflammatory Bowel Disease Progression
A clinical trial update shows recruiting status for a study on inflammatory bowel diseases, including Crohn's disease and ulcerative colitis…
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions
Completed real-world trial assessing the effectiveness of adalimumab for ulcerative colitis in routine clinical practice.
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating second-line induction therapy plus a healthy diet for Ulcerative Colitis has completed with results posted.
-
FDA approval · 2024-12-26FDA Approved: WEZLANA — Supplemental Application (Nuvaila Limited)
The FDA approved a supplemental Biologics License Application for WEZLANA (ustekinumab-auub) submitted by Nuvaila Limited.
-
FDA approval · 2024-12-20FDA Approved: USTEKINUMAB-TTWE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC. This action confirms additional regul…
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates [Phase 2]
Phase 2 study evaluating the efficacy and safety of ZYIL1 oral capsules in patients with mild to moderately active ulcerative colitis resist…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC) [Phase 1]
A Phase 1 study of LIV001 in healthy subjects and patients with Ulcerative Colitis has completed, sponsored by Liveome Inc.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
A Massachusetts General Hospital-sponsored study is recruiting to assess the risk of developing inflammatory bowel disease, including ulcera…
-
FDA approval · 2024-12-18FDA Approved: IDACIO — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for IDACIO (adalimumab-aacf) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Treatment of Ulcerative Colitis With Rectal Instillation of Qinghua Quyu Prescription(QHQYP) [NA]
A completed clinical trial evaluated the rectal instillation of Qinghua Quyu Prescription (QHQYP) for ulcerative colitis. The study was spon…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Analysis of Intestinal Defensin Expression in Acute GVHD
A completed University of Freiburg trial analyzes intestinal defensin expression in acute graft-versus-host disease. The study also relates …
-
FDA approval · 2024-12-17FDA Approved: STEQEYMA — Original Application (CELLTRION USA, Inc.)
FDA approved STEQEYMA (ustekinumab-stba) from Celltrion USA as a biosimilar to ustekinumab under an original biologics license application. …